Superworth

Beta Bionics BBNX

Medical - Instruments & Supplies, Healthcare
$15.90
−5.07%
Market cap
$864.4M
PE
n/m
a loss over the last year
Forward PE
n/m
not a meaningful number
Price to sales
6.8×
EV/EBIT
n/m
a loss over the last year
Revenue, 12 months
$127.3M
+44% on a year ago
Net margin
−65.3%
Free cash flow yield
−7.6%

Beta Bionics trades at 6.8× sales. Its trailing earnings are negative, so it has no PE. Revenue was $127.3M over the last twelve months, up 44% on a year earlier with a −65% net margin.

Charts

Financials

Income statement for BBNX, by quarter
Income statementQ1 FY24Q2 FY24Q3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26
$12.9M$15M$16.7M$20.4M$17.6M+36%$23.2M+54%$27.3M+63%$32.1M+57%$27.6M+57%$32M+38%$35.5M+30%
Cost of revenue$5.7M$7M$7.8M$8.8M$8.7M+51%$10.7M+54%$12.1M+56%$13.2M+51%$11.2M+29%$13.1M+22%$15.2M+25%
Gross profit$7.2M$8.1M$8.9M$11.7M$9M+25%$12.5M+55%$15.1M+70%$18.9M+62%$16.4M+83%$18.9M+51%$20.3M+35%
R&D$5.5M$6.3M$5.1M$9.2M$7.6M+39%$8.9M+40%$8.2M+59%$10.1M+10%$10.4M+36%$10.2M+15%$12M+46%
SG&A$11.2M$13.5M$14.8M$15.5M$20M+79%$23.5M+74%$24M+63%$24.9M+61%$30.4M+52%$34.2M+46%$35M+46%
−$9.5M−$11.8M−$11M−$13M−$18.6M+97%−$19.9M+69%−$17M+55%−$16.1M+24%−$24.3M+30%−$25.6M+29%−$26.6M+56%
Net income−$12.4M−$14.5M−$9.7M−$18.1M−$28.7M+130%−$16.9M+17%−$14.2M+46%−$13.5M−26%−$21.9M−24%−$23.4M+39%−$24.4M+71%
−$2.07−$2.37−$1.46−$2.72−$0.93−55%−$0.39−84%−$0.33−77%−$0.30−89%−$0.49−47%−$0.53+36%−$0.52+58%
6M6.1M6.7M6.7M30.7M+410%43.4M+611%43.6M+555%44.2M+563%44.4M+45%44.5M+3%46.5M+7%

EPS, diluted: Q4 FY24 and Q4 FY25: quarter's net income to common over its shares, to the cent.

Diluted shares: Q4 FY24 and Q4 FY25: a loss quarter: its basic count, share-days: the 12-month average less the 9-month, weighted by days.

From each company's 10-Q and 10-K filings, the newest version of each figure. Quarters are as filed (a fourth quarter is the year less its first nine months), fiscal years as the 10-K prints them, restated where a later 10-K restated them, and balance sheet lines as of the period's end. A quarter whose 10-Q isn't filed yet is from the company's results release. Growth is on the same period a year earlier. A dash is a period with no figure for the line: the filing doesn't print it, or it hasn't been read yet.

Peers

Companies in Medical - Instruments & Supplies nearest Beta Bionics' size, closest first.

CompanyMarket capPEIts 10y median PEFwd PEP/SRevenue growthNet margin
BBNXBeta Bionics$864.4Mn/mn/a6.8×+44%−65.3%
IRMDIradimed$1B42.5×41.5×11.4×+11%26.8%
MOVMovado$710.9M17.7×13.4×1.0×+5%6.0%
IARTIntegra Lifesciences$1.1B80.1×46.3×0.6×+1%0.8%
BVSBioventus$1.1B17.1×27.1×1.9×+4%9.4%
STAAStaar Surgical$1.3B356×144×3.7×+51%1.1%
CDRECadre$1.3B38.9×35.9×2.0×+20%5.3%
EYENational Vision$1.4B28.1×52.7×0.7×+8%2.5%
TCMDTactile Systems Technology$518.1M21.2×62.3×1.5×+17%7.1%
LMATLemaitre Vascular$1.9B28.5×42.0×7.1×+12%25.0%
INSPInspire Medical Systems$1.9B14.5×56.6×2.2×−0%15.0%
Peer median$1.2B28.3×44.1×1.9×+9%6.5%

More on Beta Bionics

Each number over time

Where it ranks

Its groups

About

Industry
Medical - Instruments & Supplies
Sector
Healthcare

Valuation data, not investment advice. Prices as of .